FDA Chief Admits He Overhyped Plasma Treatment Against COVID: ‘Criticism Is Entirely Justified’

FDA Commissioner Stephen Hahn looks during a coronavirus press briefing, in the James Brady Press Briefing Room at the White House March 19, 2020 in Washington, DC. (Photo by Brendan Smialowski / AFP) (Photo by BREND... FDA Commissioner Stephen Hahn looks during a coronavirus press briefing, in the James Brady Press Briefing Room at the White House March 19, 2020 in Washington, DC. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images) MORE LESS
Start your day with TPM.
Sign up for the Morning Memo newsletter

Food and Drug Administration Commissioner Stephen Hahn conceded on Monday night that he had exaggerated the effectiveness of convalescent plasma therapy as treatment for COVID-19 the day before.

“I have been criticized for remarks I made Sunday night about the benefits of convalescent plasma. The criticism is entirely justified,” Hahn tweeted. “What I should have said better is that the data show a relative risk reduction not an absolute risk reduction.”

The official clarified that the agency’s emergency approval of the treatment “is not a final approval” and that FDA scientists will “continue to monitor its use and will revoke authorization if needed.”

“We feel broader use of plasma will truly benefit many patients but will require further study,” he tweeted.

Hahn also denied that the authorization, which had been touted by President Donald Trump in his desperate efforts to bolster his reelection chances, was motivated by politics even as Trump pressures the FDA to approve treatment by November.

“We at FDA do not permit politics to enter into our scientific decisions,” Hahn tweeted. “This happens to be a political season but FDA will remain data driven.”

During a press briefing with Trump on Sunday, Hahn had heaped praise upon convalescent plasma therapy, claiming it had reduced the mortality rate among COVID-19 by as much as 35 percent.

“We dream in drug development of something like a 35 percent mortality reduction,” the FDA official said. “This is a major advance in the treatment of patients. This is a major advance.”

Latest News

Notable Replies

  1. I dunno. Isn’t this a bit like shutting the barn door after the cows got out?

  2. Avatar for paulw paulw says:

    In the old, fact-based days, this was the kind of thing thing led to resignations. Now it’s “Oops, my bad, let’s move on to the next lie.”

  3. Avatar for nycabj nycabj says:

    Politics? Heaven forbid? I just had a slip of the tongue - that went on for several minutes,
    My favorite thing about this article may be the photo caption.

  4. Which coincidently will be a “safe & effective” vaccine that comes out in mid-October !

  5. But Dr. Jenius von Stable says it’s a miracle cure for re-election?

Continue the discussion at forums.talkingpointsmemo.com

75 more replies

Participants

Avatar for sysprog Avatar for fargo116 Avatar for clemmers Avatar for steviedee111 Avatar for progress Avatar for dont Avatar for christianhankel Avatar for 26degreesrising Avatar for darrtown Avatar for pshah Avatar for citytrucker Avatar for texastwostep Avatar for darwinwasright Avatar for susanintheoc Avatar for greysea Avatar for not_so_fluffy Avatar for coimmigrant Avatar for centralasiaexpat Avatar for luckie Avatar for iamsmall Avatar for dougsanders Avatar for haddockbranzini Avatar for easternash Avatar for rogerhead

Continue Discussion
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: